Podcast appearances and mentions of peter nordstr

Hans nummer 19 hänger i taket i Löfbergs Arena och han pratar fortfarande om Färjestad som "vi" 15 år efter att han lämnat. När Peter Nordström nu gästar VF Hockey berättar han om hur skulle vilja se värmländsk ishockey förändras, de miljoner han lämnade på bordet för att få spela och vinna med Färjestad, om hockeytvillingen Jörgen Jönsson och mycket annat. Dags att börja prenumerera på VF? Just nu får du de två första månaderna för endast 19 kronor – klicka här för att komma till erbjudandet! Vill du marknadsföra ditt företag i våra poddar? Kontakta oss på mediepartner@nwtmedia.se eller ring 054-19 90 00. Såklart du ska skaffa bredbandskund hos oss! Klicka här för att komma till erbjudandet!

Många höjde på ögonbrynen när bröderna Colling lämnade Karlstad. Nya tränaren med en mycket framgångsrik bakgrund inom ishockey, Peter “Norda” Nordström, kom in med en ny filosofi. I detta avsnitt gästas vi av kaptenen Gustav Agnemyr som ger en inblick bakom kulisserna när Karlstad förändrades och tog sig tillbaka till SSL.Hålltider05.45: Peter Nordströms ”städning”09.26: Positionsbytet till back12.00: ”Kan gå käpprätt åt helvete”16.50: Spelare som tagit stora kliv32.55: Därför ska man se Karlstad spela37.20: Hur kommer det gå för nykomlingarna?43.45: Nya Allsvenskan - ”Riktigt tufft”47.55: Hur ska Galante Carlström stoppas?49.50: ”Försvarsspelet måste sitta”Lyssna på hela avsnittet på Innebandymagazinet.se som Plus-medlem. Hosted on Acast. See acast.com/privacy for more information.

Idag är cancer den överlägset främsta orsaken till död före 80 års ålder. Men det finns de som anser att det inte behöver vara så. Att cancer skulle kunna elimineras som dödsorsak och i större utsträckning än idag bli en botbar eller kronisk sjukdom, men är det verkligen möjligt och vad kommer i så fall krävas? I avsnitt 33 av Sjukvårdspodden pratar Jonas Edström och Eleonore Lundkvist om möjligheten att utrota cancer som dödsorsak med Ebba Hallersjö Hult, innovationsledare för innovationsmiljön Nollvision Cancer och Barbro Sjölander, ordförande i nätverket mot gynekologisk cancer. Ni får också en spaning från Peter Nordström, programchef på Swelife.

Dr Peter A. McCullough, MD, MPH, is a board-certified cardiologist, internist, epidemiologist who has testified before committees of the US and multiple State Senates regarding the treatment of COVID-19 and management of the ongoing pandemic. He has been in practice for over 40 years as an active treating physician combined with a decorative academic career that has placed him the most published cardiologist of all time. Join us as we explore:If it is safe to vaccinate your children The very real risk of myocarditis If you can get C-19 twice, why vaccinating post-COVID infection is dangerous, a huge amount of false + cases, C-19's mass psychosis The overwhelming evidence natural immunity is “complete, robust and durable” and “infinitely” superior to vaccinationMENTIONS:Avolio, E., et al. (2021). The SARS-CoV-2 Spike protein disrupts human cardiac pericytes function through CD147 receptor-mediated signalling: a potential non-infective mechanism of COVID-19 microvascular disease. Clinical science (London, England : 1979), 135(24), 2667–2689. https://doi.org/10.1042/CS20210735 SARS-CoV-2 mRNA Vaccination-Associated Myocarditis in Children Ages 12-17: A Stratified National Database Analysis. Tracy Beth Høeg, et al.medRxiv 2021.08.30.21262866; doi: https://doi.org/10.1101/2021.08.30.21...    Lim, Y., Kim, M. C., Kim, K. H., Jeong, I. S., Cho, Y. S., Choi, Y. D., & Lee, J. E. (2021). Case Report: Acute Fulminant Myocarditis and Cardiogenic Shock After Messenger RNA Coronavirus Disease 2019 Vaccination Requiring Extracorporeal Cardiopulmonary Resuscitation. Frontiers in cardiovascular medicine, 8, 758996. https://doi.org/10.3389/fcvm.2021.758996 Choi, S., Lee, et al.  (2021). Myocarditis-induced Sudden Death after BNT162b2 mRNA COVID-19 Vaccination in Korea: Case Report Focusing on Histopathological Findings. Journal of Korean medical science, 36(40), e286. https://doi.org/10.3346/jkms.2021.36....Professor Mattias Desmet https://www.ugent.be/psync/en/who/des...Shedding of Infectious SARS-CoV-2 Despite VaccinationKasen et al. medRxiv 2021.07.31.21261387; doi: https://doi.org/10.1101/2021.07.31.21... 141 Studies Showing Natural Immunity (up from 128)https://brownstone.org/articles/79-re... https://www.thegatewaypundit.com/2021... “Risks of Vaccines for Those Recovered from COVID-19 – Krammer, Raw & Mathioudakis”https://www.americaoutloud.com/risks-...  Cohn, B. A., et al (2021). SARS-CoV-2 vaccine protection and deaths among US veterans during 2021. Science (New York, N.Y.), eabm0620. Advance online publication. https://doi.org/10.1126/science.abm0620Effectiveness of heterologous ChAdOx1 nCoV-19 and mRNA prime-boost vaccination against symptomatic Covid-19 infection in Sweden: A nationwide cohort study. Peter Nordström, et al. The Lancet Regional Health – Europe.  December 2021. https://www.thelancet.com/journals/la...  “Failure of Vaccines and Truth Revealed”. https://www.americaoutloud.com/failur... COVID-19-associated hospitalizations among vaccinated and unvaccinated adults ≥18 years – COVID-NET, 13 states, January 1 – July 24, 2021. Fiona P. Havers, et al. medRxiv 2021.08.27.21262356; doi:https://doi.org/10.1101/2021.08.27.21...Antigenic minimalism of SARS-CoV-2 is linked to surges in COVID-19 community transmission and vaccine breakthrough infections. A.J. Venkatakrishnan, et al. medRxiv 2021.05.23.21257668; doi:https://doi.org/10.1101/2021.05.23.21...Kostoff, R. N., et al. (2021). Why are we vaccinating children against COVID-19?. Toxicology reports, 8, 1665–1684. https://doi.org/10.1016/j.toxrep.2021...Disclaimer policy for all of our videos. https://madetothrive.co.za/terms-and-...

Dass Gesundheitsrisiken gesellschaftlich ungleich verteilt sind, ist lange bekannt. Trotzdem trägt die Pandemiepolitik dem nicht Rechnung. Das Coronavirus trifft arme und bildungsferne Menschen besonders hart, und das nicht nur beim Infektionsrisiko, sondern auch, was den Krankheitsverlauf angeht. In einer Sonderfolge spricht Wissenschaftsredakteurin Korinna Hennig mit dem Medizinsoziologen Nico Dragano über die sozioökonomische Seite der Corona-Krise. Er erklärt, was man aus früheren Pandemien hätte lernen können, welche Rolle Nahverkehr und Arbeitsplätze spielen - und was man anders machen müsste. Die Hintergrundinformationen • Sozioökonomische Ungleichheit und COVID-19 | Robert Koch-Insititut: Eine Übersicht über den internationalen Forschungsstand https://edoc.rki.de/handle/176904/6965 • Risikofaktoren und Covid-19-Tests in Großbritannien | Marc Chadeau-Hyam, Barbara Bodinier, Joshua Elliott, Matthew D Whitaker, Ioanna Tzoulaki, Roel Vermeulen, Michelle Kelly-Irving, Cyrille Delpierre und Paul Elliott: "Risk factors for positive and negative COVID-19 tests: a cautious and in-depth analysis of UK biobank data", erschienen August 2020 bei Oxford Academic https://academic.oup.com/ije/article/49/5/1454/5894660?login=true • Covid-19 Inzidenz und Sterberate in Abhängigkeit von schlechten Wohnverhältnissen in den USA | Khansa Ahmad, Sebhat Erqou, Nishant Shah, Umair Nazir, Alan R. Morrison, Gaurav Choudhary und Wen-Chih Wu: "Association of poor housing conditions with COVID-19 incidence and mortality across US counties", erschienen November 2020 bei PLOS ONE https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0241327 • Mobilität und Nahverkehr in der Corona-Pandemie in New York | Karla Therese L. Sy, Micaela E. Martinez, Benjamin Rader und Laura F. White: "Socioeconomic disparities in subway use and COVID-19 outcomes in New York City", erschienen Mai 2020 auf medRxiv https://www.medrxiv.org/content/10.1101/2020.05.28.20115949v1.full.pdf • Mobilität und Ungleichheit | Serina Chang, Emma Pierson, Pang Wei Koh, Jaline Gerardin, Beth Redbird, David Grusky und Jure Leskovec: "Mobility network models of COVID-19 explain inequities and inform reopening", erschienen November 2020 bei Nature https://www.nature.com/articles/s41586-020-2923-3.pdf • Studie aus Israel zum Zugang zu Tests und Infektionsrisiken in der Corona-Pandemie | Khitam Muhsen, Wasef Na'aminh, Yelena Lapidot, Sophy Goren, Yonatan Amir, Saritte Perlman, Manfred S. Green, Gabriel Chodick und Dani Cohen: "A nationwide analysis of population group differences in the COVID-19 epidemic in Israel, February 2020–February 2021", erschienen August 2020 in The Lancet Regional Health - Europe auf ScienceDirect https://www.sciencedirect.com/science/article/pii/S2666776221001071 • Risikofaktoren und Krankheitsverläufe in Schweden | Jonathan Bergman, Marcel Ballin, Anna Nordström und Peter Nordström: "Risk factors for COVID-19 diagnosis, hospitalization, and subsequent all-cause mortality in Sweden: a nationwide study", erschienen März 2021 in European Journal of Epidemiology volume bei Springer Nature https://link.springer.com/article/10.1007/s10654-021-00732-w • Risikofaktoren und Krankheitsverläufe in Großbritannien | Joshua Elliott, Barbara Bodinier, Matthew Whitaker, Cyrille Delpierre, Roel Vermeulen, Ioanna Tzoulaki, Paul Elliott und Marc Chadeau-Hyam: "COVID-19 mortality in the UK Biobank cohort: revisiting and evaluating risk factors", erschienen Februar 2021 im European Journal of Epidemiology bei Springer Nature https://link.springer.com/article/10.1007/s10654-021-00722-y • Erhöhtes Risiko eines COVID-19-bedingten Krankenhausaufenthaltes für Arbeitslose | Morten Wahrendorf, Christoph J. Rupprecht, Olga Dortmann, Maria Scheider und Nico Dragano: Eine Analyse von Krankenkassendaten von 1,28 Mio. Versicherten in Deutschland, erschienen Januar 2021 im Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz auf Springer Nature https://link.springer.com/article/10.1007%2Fs00103-021-03280-6 • Inzidenz und Sterblichkeit in Abhängigkeit vom sozialen Status in Chile | Gonzalo E. Mena, Pamela P. Martinez, Ayesha S. Mahmud, Pablo A. Marquet, Caroline O. Buckee und Mauricio Santillana: "Socioeconomic status determines COVID-19 incidence and related mortality in Santiago, Chile", erschienen Mai 2021 bei Science https://science.sciencemag.org/content/372/6545/eabg5298.abstract • Impfungen und Bevölkerungsgruppen - Studie aus Italien | Alexander Domnich, Maura Cambiaggi, Alessandro Vasco, Luca Maraniello, Filippo Ansaldi, Vincenzo Baldo, Paolo Bonanni, Giovanna Elisa Calabrò, Claudio Costantino, Chiara de Waure, Giovanni Gabutti, Vincenzo Restivo, Caterina Rizzo, Francesco Vitale und Riccardo Grassi: "Attitudes and Beliefs on Influenza Vaccination during the COVID-19 Pandemic: Results from a Representative Italian Survey", erschienen November 2020 bei MDPI https://www.mdpi.com/2076-393X/8/4/711 • Grippe und Impfung bei 65+ | Jason M Nagata, Isabel Hernández-Ramos, Anand Sivasankara Kurup, Daniel Albrecht, Claudia Vivas-Torrealba und Carlos Franco-Paredes, "Social determinants of health and seasonal influenza vaccination in adults ≥65 years: a systematic review of qualitative and quantitative data", erschienen April 2013 bei BMC (Springer Nature) https://bmcpublichealth.biomedcentral.com/articles/10.1186/1471-2458-13-388 • Daten aus früheren Pandemien - Hohe Sterberaten bei niedrigem sozialen Status | "Social inequality - a forgotten factor in pandemic influenza preparedness", erschienen Juni 2017 bei Tidsskrift for Den norske legeforening Oslo https://tidsskriftet.no/2017/05/global-helse/social-inequality-forgotten-factor-pandemic-influenza-preparedness • Frühere Pandemien - SARS | Grace Wong Bucchianeri: "Is SARS a Poor Man's Disease? Socioeconomic Status and Risk Factors for SARS Transmission", erschienen 2010 in Forum for Health Economics & Policy https://www.degruyter.com/document/doi/10.2202/1558-9544.1209/html • Frühere Pandemien - Blick auf Chicago 1918 | Kyra H. Grantz, Madhura S. Rane, Henrik Salje, Gregory E. Glass, Stephen E. Schachterle, and Derek A. T. Cummings: "Disparities in influenza mortality and transmission related to sociodemographic factors within Chicago in the pandemic of 1918", erschienen November 2016 bei PNAS https://www.pnas.org/content/113/48/13839.short • Ungleichheit und Epidemien als Herausforderung für die globale Sicherheit | Sandra Crouse Quinn und Supriya Kumar: "Health Inequalities and Infectious Disease Epidemics: A Challenge for Global Health Security", erschienen September 2014 im Biosecurity and Bioterrorism: Biodefense Strategy, Practice, and Science bei Mary Ann Liebert, Inc., publishers https://www.liebertpub.com/doi/abs/10.1089/bsp.2014.0032

Dass Gesundheitsrisiken gesellschaftlich ungleich verteilt sind, ist lange bekannt. Trotzdem trägt die Pandemiepolitik dem nicht Rechnung. Das Coronavirus trifft arme und bildungsferne Menschen besonders hart, und das nicht nur beim Infektionsrisiko, sondern auch, was den Krankheitsverlauf angeht. In einer Sonderfolge spricht Wissenschaftsredakteurin Korinna Hennig mit dem Medizinsoziologen Nico Dragano über die sozioökonomische Seite der Corona-Krise. Er erklärt, was man aus früheren Pandemien hätte lernen können, welche Rolle Nahverkehr und Arbeitsplätze spielen - und was man anders machen müsste. Die Hintergrundinformationen • Sozioökonomische Ungleichheit und COVID-19 | Robert Koch-Insititut: Eine Übersicht über den internationalen Forschungsstand https://edoc.rki.de/handle/176904/6965 • Risikofaktoren und Covid-19-Tests in Großbritannien | Marc Chadeau-Hyam, Barbara Bodinier, Joshua Elliott, Matthew D Whitaker, Ioanna Tzoulaki, Roel Vermeulen, Michelle Kelly-Irving, Cyrille Delpierre und Paul Elliott: "Risk factors for positive and negative COVID-19 tests: a cautious and in-depth analysis of UK biobank data", erschienen August 2020 bei Oxford Academic https://academic.oup.com/ije/article/49/5/1454/5894660?login=true • Covid-19 Inzidenz und Sterberate in Abhängigkeit von schlechten Wohnverhältnissen in den USA | Khansa Ahmad, Sebhat Erqou, Nishant Shah, Umair Nazir, Alan R. Morrison, Gaurav Choudhary und Wen-Chih Wu: "Association of poor housing conditions with COVID-19 incidence and mortality across US counties", erschienen November 2020 bei PLOS ONE https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0241327 • Mobilität und Nahverkehr in der Corona-Pandemie in New York | Karla Therese L. Sy, Micaela E. Martinez, Benjamin Rader und Laura F. White: "Socioeconomic disparities in subway use and COVID-19 outcomes in New York City", erschienen Mai 2020 auf medRxiv https://www.medrxiv.org/content/10.1101/2020.05.28.20115949v1.full.pdf • Mobilität und Ungleichheit | Serina Chang, Emma Pierson, Pang Wei Koh, Jaline Gerardin, Beth Redbird, David Grusky und Jure Leskovec: "Mobility network models of COVID-19 explain inequities and inform reopening", erschienen November 2020 bei Nature https://www.nature.com/articles/s41586-020-2923-3.pdf • Studie aus Israel zum Zugang zu Tests und Infektionsrisiken in der Corona-Pandemie | Khitam Muhsen, Wasef Na'aminh, Yelena Lapidot, Sophy Goren, Yonatan Amir, Saritte Perlman, Manfred S. Green, Gabriel Chodick und Dani Cohen: "A nationwide analysis of population group differences in the COVID-19 epidemic in Israel, February 2020–February 2021", erschienen August 2020 in The Lancet Regional Health - Europe auf ScienceDirect https://www.sciencedirect.com/science/article/pii/S2666776221001071 • Risikofaktoren und Krankheitsverläufe in Schweden | Jonathan Bergman, Marcel Ballin, Anna Nordström und Peter Nordström: "Risk factors for COVID-19 diagnosis, hospitalization, and subsequent all-cause mortality in Sweden: a nationwide study", erschienen März 2021 in European Journal of Epidemiology volume bei Springer Nature https://link.springer.com/article/10.1007/s10654-021-00732-w • Risikofaktoren und Krankheitsverläufe in Großbritannien | Joshua Elliott, Barbara Bodinier, Matthew Whitaker, Cyrille Delpierre, Roel Vermeulen, Ioanna Tzoulaki, Paul Elliott und Marc Chadeau-Hyam: "COVID-19 mortality in the UK Biobank cohort: revisiting and evaluating risk factors", erschienen Februar 2021 im European Journal of Epidemiology bei Springer Nature https://link.springer.com/article/10.1007/s10654-021-00722-y • Erhöhtes Risiko eines COVID-19-bedingten Krankenhausaufenthaltes für Arbeitslose | Morten Wahrendorf, Christoph J. Rupprecht, Olga Dortmann, Maria Scheider und Nico Dragano: Eine Analyse von Krankenkassendaten von 1,28 Mio. Versicherten in Deutschland, erschienen Januar 2021 im Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz auf Springer Nature https://link.springer.com/article/10.1007%2Fs00103-021-03280-6 • Inzidenz und Sterblichkeit in Abhängigkeit vom sozialen Status in Chile | Gonzalo E. Mena, Pamela P. Martinez, Ayesha S. Mahmud, Pablo A. Marquet, Caroline O. Buckee und Mauricio Santillana: "Socioeconomic status determines COVID-19 incidence and related mortality in Santiago, Chile", erschienen Mai 2021 bei Science https://science.sciencemag.org/content/372/6545/eabg5298.abstract • Impfungen und Bevölkerungsgruppen - Studie aus Italien | Alexander Domnich, Maura Cambiaggi, Alessandro Vasco, Luca Maraniello, Filippo Ansaldi, Vincenzo Baldo, Paolo Bonanni, Giovanna Elisa Calabrò, Claudio Costantino, Chiara de Waure, Giovanni Gabutti, Vincenzo Restivo, Caterina Rizzo, Francesco Vitale und Riccardo Grassi: "Attitudes and Beliefs on Influenza Vaccination during the COVID-19 Pandemic: Results from a Representative Italian Survey", erschienen November 2020 bei MDPI https://www.mdpi.com/2076-393X/8/4/711 • Grippe und Impfung bei 65+ | Jason M Nagata, Isabel Hernández-Ramos, Anand Sivasankara Kurup, Daniel Albrecht, Claudia Vivas-Torrealba und Carlos Franco-Paredes, "Social determinants of health and seasonal influenza vaccination in adults ≥65 years: a systematic review of qualitative and quantitative data", erschienen April 2013 bei BMC (Springer Nature) https://bmcpublichealth.biomedcentral.com/articles/10.1186/1471-2458-13-388 • Daten aus früheren Pandemien - Hohe Sterberaten bei niedrigem sozialen Status | "Social inequality - a forgotten factor in pandemic influenza preparedness", erschienen Juni 2017 bei Tidsskrift for Den norske legeforening Oslo https://tidsskriftet.no/2017/05/global-helse/social-inequality-forgotten-factor-pandemic-influenza-preparedness • Frühere Pandemien - SARS | Grace Wong Bucchianeri: "Is SARS a Poor Man's Disease? Socioeconomic Status and Risk Factors for SARS Transmission", erschienen 2010 in Forum for Health Economics & Policy https://www.degruyter.com/document/doi/10.2202/1558-9544.1209/html • Frühere Pandemien - Blick auf Chicago 1918 | Kyra H. Grantz, Madhura S. Rane, Henrik Salje, Gregory E. Glass, Stephen E. Schachterle, and Derek A. T. Cummings: "Disparities in influenza mortality and transmission related to sociodemographic factors within Chicago in the pandemic of 1918", erschienen November 2016 bei PNAS https://www.pnas.org/content/113/48/13839.short • Ungleichheit und Epidemien als Herausforderung für die globale Sicherheit | Sandra Crouse Quinn und Supriya Kumar: "Health Inequalities and Infectious Disease Epidemics: A Challenge for Global Health Security", erschienen September 2014 im Biosecurity and Bioterrorism: Biodefense Strategy, Practice, and Science bei Mary Ann Liebert, Inc., publishers https://www.liebertpub.com/doi/abs/10.1089/bsp.2014.0032

Researchers study preventing cancer and diabetes with the maqui berry NOVA Southeastern University of Florida, May 27, 2021 Aristotelia chilensis, also known as maqui berry, is a fruit-bearing shrub native to South America.  According to a study published in the journal Phytochemical Analysis, maqui berries are rich in anthocyanins, which give the fruits their dark purple color. Anthocyanins are plant pigments that possess many remarkable biological properties, such as antioxidant, anti-inflammatory, anti-viral and anti-cancer activities. In a recent study, researchers at NOVA Southeastern University in Florida discussed the potential of Chilean maqui berry for use as a nutritional supplement that can help treat hyperinsulinemia and related diseases. Hyperinsulinemia, or higher-than-normal insulin levels, is often caused by insulin resistance, which is said to be the precursor to diabetes. Chronic hyperinsulinemia also promotes cancer growth by allowing insulin to exert its oncogenic effects, which include enhancing growth factor-dependent cell proliferation, among others. The researchers discussed how Chilean maqui berry can help with insulin resistance and reduce cancer risk in an article published in the journal Food Science and Human Wellness. The medicinal benefits of Chilean maqui berry Researchers have long considered nutritional supplementation to be a possible alternative or adjunct treatment to conventional therapies for common ailments and diseases. According to recent studies, maqui berries can reduce postprandial insulin levels by as much as 50 percent and are just as effective as metformin at increasing insulin sensitivity and stabilizing blood glucose levels. Maqui berries’ mechanism of action involves inhibiting sodium-dependent glucosetransporters in the small intestine and slowing the rate of entry of glucose in the bloodstream. Thanks to these actions, maqui berries can effectively reduce the likelihood of blood sugar spikes and prevent the corresponding rise in insulin levels that follows.  At the same time, maqui berries contribute to cancer prevention since chronically high blood glucose levels — besides chronic hyperinsulinemia — are also linked to the development of cancer. In fact, numerous studies have shown that diabetics and prediabetics have an elevated risk of developing cancerous growths. Based on the findings of previous studies, the researchers believe that consistent supplementation with Chilean maqui berries could indirectly reduce the risk of cancer and other diseases that are promoted by hyperglycemia (high blood sugar) and hyperinsulinemia.     Studies reveal that social isolation and quarantine throughout the COVID-19 pandemic may have a detrimental impact on physical and mental health of people living with pre-existing conditions University of Naples (Italy) and Teva Pharmaceuticals, May 30, 2021   Abstract 803: Impact of social isolation and quarantine on the course of diabetes mellitus and its complications during Covid 19 pandemic in Adjara Region Country of Georgia Abstract 1337: Psychological distress in patients with hypocortisolism during mass quarantine for Covid-19 epidemic in Italy Studies reveal that social isolation and quarantine throughout the COVID-19 pandemic may have a detrimental impact on people living with pre-existing conditions.  Social isolation and quarantine can have a detrimental impact on physical and mental health of people living with pre-existing conditions, according to two studies being presented at the 23rd European Congress of Endocrinology (e-ECE 2021)  The studies bring together research on the impact of social isolation and quarantine for people living with diabetes in the Adjara Region of Georgia, and on patients with hypocortisolism in Italy. Both studies reported that social isolation during the pandemic caused significant psychological and/or physical distress on the observed individuals.  Data from the first study revealed that the impact of quarantine on people living with diabetes in the Adjara Region caused blood pressure (BP) levels to increase in 88.2% of patients with 50% of these cases resulting in high BP hospitalisation. In addition to these physical factors, increased feelings of anxiety and fear were observed on 82% of patients. In the second study, patients with hypocortisolism experienced increased anxiety and depression, associated with a dissatisfaction feeling of self and a reduced resiliency, when compared with Italian healthy controls. As these are all contributing factors to overall health deterioration, these findings suggest further research is required to allow patients with pre-existing conditions to remain fit and healthy during the current pandemic. In the Adjara Region study, Dr Liana Jashi and the research team disseminated an online questionnaire and collected answers from 16 endocrinologists and 22 family and general practice doctors. The study confirmed the negative, indirect effects social isolation and quarantine had on people living with diabetes. It reported a list of negative effects such as the reduced access to medical care, weight gain and increased cigarette and alcohol consumption. Physical activity decreased by 29.8%, a vital preventative to further physical and psychological problems.  "This study highlights that people living with diabetes require greater support during pandemics to maintain exercise and protect their physical and mental health. National health services should use these data and future studies to implement better social care around supporting people with pre-existing conditions," commented Dr Jashi. In the second study, Dr Chiara Simeoli at the University of Naples reported data collected during the last three weeks of the mass quarantine lasted 2 months in Italy, in a web-survey-based, multicenter, case- control research involving 12 different Italian centres. The study confirmed that a large cohort of 478 patients with hypocortisolism, and particularly, 363 with adrenal insufficiency and 115 with congenital adrenal hyperplasia, adequately treated with glucocorticoids, showed higher anxiety and depression, associated with a dissatisfaction feeling of self and a reduced resiliency, when compared with Italian healthy controls, suggesting the detrimental impact of social isolation on mental health of these patients, particularly frail and vulnerable to infections and stress. Moreover, patients with adrenal insufficiency reported a worse quality of life than patients with congenital adrenal hyperplasia.  "These findings confirmed that beyond the huge impact on physical health, COVID-19 epidemic, social isolation and mass quarantine represent significant psychological stressors, causing severe effects on mental health, even more on people with pre-existing conditions. An empowerment of psychological counselling for these vulnerable patients during COVID-19 should be considered by national health-care services," adds Dr Simeoli.  Both studies indicate that additional larger studies over a longer period of time are needed for further investigation.       Researchers discover link between local oxygen depletion in the brain and Alzheimer's disease University of Seville (Spain), May 24, 2021 The study, published in the journal Nature Aging and led by the laboratories of Dr. Alberto Pascual (CSIC), from the Neuronal Maintenance Mechanisms Group, and Prof. Javier Vitorica (University of Seville/CIBERNED) of the Physiopathology of Alzheimer's Disease Group at IBiS, demonstrates for the first time that low oxygen levels in the so-called senile plaques in the brain reduces the immune system's defensive capacity against the disease. The study also suggests that this lack of oxygen in the brain enhances the action of disorders associated with Alzheimer's disease that are characterized by low systemic oxygen levels, such as atherosclerosis and other cardiovascular diseases. What happens in the brain? A characteristic feature of Alzheimer's patients is the accumulation of highly toxic substances in their brains, known as senile plaques. The brain has an immune system whose main component are the microglial cells, which were first described and named 100 years ago by Pío del Río Hortega, a disciple of Ramón y Cajal. In the absence of damage, these cells facilitate the neurons' function. In response to Alzheimer's disease, microglia defend neurons by surrounding senile plaques, preventing their spread in the brain and decreasing damage. Alzheimer's disease is aggravated by other pathologies, such as cardiovascular diseases, which cause a decrease in oxygen levels in the body. This study has revealed reduced oxygen levels around senile plaques, compromising microglial activity (Image, center). When this is compounded by reduced oxygen supply to the brain due to other systemic pathologies, the microglia are unable to provide protection and there is an increase in the pathology associated with the disease. Relevance Alzheimer's disease is the leading cause of dementia in Spain and around the world. In Spain, its incidence is increasing dramatically as the population ages. Unfortunately, the origin of the disease remains unknown. The mechanism proposed in this study is mediated by the expression of the HIF1 molecule, whose discoverers received the Nobel Prize in Physiology or Medicine in 2019. Increased HIF1 levels compromise the mitochondrial activity of microglial cells and limit their protective capacity against disease. This study opens new lines of research to improve the metabolic capacity of microglia, which would enable a sustained response over time against the disease. Indirectly, the study supports previous work highlighting the importance of maintaining good cardiovascular health for healthy aging.   Effect of different doses of melatonin on learning and memory deficit in Alzheimer model Guilan University of Medical Sciences (Iran), May 21, 2021   According to news reporting out of Rasht, Iran, research stated, “Alzheimer Disease (AD) is an age-related neurodegenerative disorder with a progressive impairment of cognitive function. The pineal gland hormone melatonin (MEL) has been known as a protection agent against AD.” Our news reporters obtained a quote from the research from Guilan University of Medical Sciences: “However, the effect of melatonin in various doses is inconsistent. In this study, we aimed to investigate two doses of MEL on learning and memory in the amyloid-beta (Ab)-induced AD in the rats. Forty-eight male Wistar rats were used in the experiment and randomly divided control, sham, vehicle, AD, AD+MEL10 mg/kg, and AD+MEL 20 mg/kg groups. Intracerebroventricular injection of Ab1-42 was used to develop the animal model of AD. Also, MEL-treated groups received an intraperitoneal injection of MEL for 4 next weeks. The Morris Water Maze (MWM) and Passive Avoidance Learning (PAL) tests were used to examine animals’ learning and memory. The brain of animals was removed for immunohistochemistry for anti- Amyloid Precursor Protein (APP). Intra-peritoneal injection of MEL significantly improve learning and memory in MWM (P=0.000) and PAL test (P=0.000), but there were no significant changes in the two groups that received the melatonin (P>0.05). Histopathological analysis revealed that the clearance of APP deposition in the AD+MEL20 group was considerable compared with the AD+MEL10 group (P=0.000).” According to the news editors, the research concluded: “Our findings indicate that 10 and 20 mg/kg doses of melatonin have similar results on learning and memory in the AD model. But 20 mg/kg of melatonin has significantly more effect on the clearance of APP deposition.”     Effects of flaxseed on blood pressure, body mass index, and total cholesterol in hypertensive patients: A randomized clinical trial Lorestan University of Medical Sciences (Iran), May 25, 2021 Objectives Given the antioxidant properties of flaxseed and its biologically active ingredients, this study was conducted to determine the effects of flaxseed supplementation on body mass index (BMI), blood pressure, and total cholesterol levels in patients with hypertension. Methods In this triple-blind clinical trial, 112 patients, with an age range of 35 to 70 years, were randomized to 2 groups receiving 10 g (n=45) and 30 g (n=45) of flaxseed supplementation and 1 group receiving placebo (n=45) for 12 weeks by stratified block randomization. They were evaluated in terms of systolic (SBP) and diastolic blood pressure (DBP), BMI, and total serum cholesterol. Physical activity was measured using the International Physical Activity Questionnaire–Short Form (IPAQ–SF) and food intake was assessed using the Food Frequency Questionnaire (FFQ). The data were analyzed with SPSS, version 22, using the chi-square, Kruskal–Wallis, repeated measures analysis, ANOVA, and ANCOVA tests. Results The interaction effects among the study groups and time on the mean SBP (p = 0.001), DBP (p = 0.001), total cholesterol level (p = 0.032), and BMI (p < 0.001) were significant. During the study, the 30-g group achieved the best results, so that a 13.38-unit decrease in SBP was observed compared to a 1.72 unit increase in the placebo group and a 5.6-unit decrease in DBP was measured compared to a 2.39 unit increase in the placebo group. BMI decreased by 0.86 units compared to 0.06 units in the placebo group. Total cholesterol also decreased by 20.4 units compared to 11.86 units in the placebo group. Conclusion The results of this study showed that flaxseed can be effective in reducing blood pressure, total cholesterol, and body mass index in hypertensive patients in a twelve-week period.     Study: Don't count on caffeine to fight sleep deprivation Michigan State University, May 27, 2021 Rough night of sleep? Relying on caffeine to get you through the day isn't always the answer, says a new study from Michigan State University. Researchers from MSU's Sleep and Learning Lab, led by psychology associate professor Kimberly Fenn, assessed how effective caffeine was in counteracting the negative effects of sleep deprivation on cognition. As it turns out, caffeine can only get you so far. The study -- published in the most recent edition of Journal of Experimental Psychology: Learning, Memory, & Cognition -- assessed the impact of caffeine after a night of sleep deprivation. More than 275 participants were asked to complete a simple attention task as well as a more challenging "placekeeping" task that required completion of tasks in a specific order without skipping or repeating steps. Fenn's study is the first to investigate the effect of caffeine on placekeeping after a period of sleep deprivation. "We found that sleep deprivation impaired performance on both types of tasks and that having caffeine helped people successfully achieve the easier task. However, it had little effect on performance on the placekeeping task for most participants," Fenn said. She added: "Caffeine may improve the ability to stay awake and attend to a task, but it doesn't do much to prevent the sort of procedural errors that can cause things like medical mistakes and car accidents."  Insufficient sleep is pervasive in the United States, a problem that has intensified during the pandemic, Fenn said. Consistently lacking adequate sleep not only affects cognition and alters mood, but can eventually take a toll on immunity.  "Caffeine increases energy, reduces sleepiness and can even improve mood, but it absolutely does not replace a full night of sleep, Fenn said. "Although people may feel as if they can combat sleep deprivation with caffeine, their performance on higher-level tasks will likely still be impaired. This is one of the reasons why sleep deprivation can be so dangerous." Fenn said that the study has the potential to inform both theory and practice.  "If we had found that caffeine significantly reduced procedural errors under conditions of sleep deprivation, this would have broad implications for individuals who must perform high stakes procedures with insufficient sleep, like surgeons, pilots and police officers," Fenn said. "Instead, our findings underscore the importance of prioritizing sleep."     Parkinson's disease more likely in people with depression, study suggests Umea University (Sweden), May 21 2021     People with depression may be more likely to develop the movement disorder Parkinson's disease, according to new research published in Neurology.   According to the authors of the study, depression is more common in people with Parkinson's disease than those without the movement disorder. "We saw this link between depression and Parkinson's disease over a timespan of more than 2 decades, so depression may be a very early symptom of Parkinson's disease or a risk factor for the disease," says study co-author Prof. Peter Nordström, at Umeå University in Sweden. Parkinson's disease is a progressive disorder of the nervous system that affects how a person moves, including how they speak and write. As well as problems with movement, Parkinson's disease can also cause cognitive problems, neurobehavioral problems and sensory difficulties. The authors of the study state that depression is more common in patients with Parkinson's disease than in members of the general population. The mood disorder has a major influence on health-related quality of life and could also be involved in more rapid deterioration of cognitive and motor functions. However, few studies have investigated this association for periods of longer than 10 years, with any long-term findings so far inconclusive. For the study, the researchers used a cohort consisting of all Swedish citizens aged 50 years and above as of December 31st, 2005. From this group, they then took the 140,688 people diagnosed with depression . These individuals were each matched with three control participants (a total of 421,718 controls) of the same age and sex who had not been diagnosed with depression. The participants were then followed for up to 26 years. A total of 1,485 people with depression (1.1%) developed Parkinson's disease during this time, compared with 1,775 of those who did not have depression (0.4%). On average, Parkinson's disease was diagnosed 4.5 years after the beginning of the study, with the likelihood of the disorder developing decreasing over time. No sibling link found for depression and Parkinson's disease The researchers calculated that participants with depression were 3.2 times more likely than those without depression to develop Parkinson's disease within a year of the study beginning. After 15-25 years, the researchers found participants with depression were almost 50% more likely to develop the condition. If a participant's depression was severe, their likelihood of developing Parkinson's disease was also higher. For example, those who had been hospitalized for depression five or more times were 40% more likely to develop Parkinson's disease than participants who had been hospitalized for depression just once. In addition to these observations, the researchers examined siblings. No link was found between one sibling having Parkinson's disease and the other having depression. "This finding gives us more evidence that these two diseases are linked," says Prof. Nordström. "If the diseases were independent of each other but caused by the same genetic or early environmental factors, then we would expect to see the two diseases group together in siblings, but that didn't happen." The authors suggest there are a number of mechanisms that could explain their findings. Depression or antidepressive treatment could increase the risk of Parkinson's disease, depression could be an early symptom of Parkinson's disease, or that the two conditions could share environmental causative factors. In the paper, the authors acknowledge that they are unable to evaluate the potential role of substances used in antidepressive treatment as risk factors for Parkinson's disease. The study is an observational one and cannot determine causation. "Our findings suggest a direct association between depression and subsequent [Parkinson's disease], supported by a time-dependent hazard ratio, a dose-response pattern for recurrent depression, and a lack of evidence for coaggregation among siblings," the authors conclude. "Given that the association was significant over more than two decades of follow-up, depression may be a very early prodromal symptom of or a causal risk factor for [Parkinson's disease]." Elsewhere, a study published in December previously suggested that users of methamphetamine are at three times more risk of getting Parkinson's disease than people who do not use illegal drugs.

I veckans avsnitt pratar Mikael Mjörnberg och Henrik Skoglund naturligtvis om effekterna av att IK Pantern begärt sig i konkurs. Men det blir också mycket snack om elitlicensgranskningar, kopplingen mellan AIK och Väsby, Gripens eventuella namnbyte och fulsnygga matchdräkter. Dessutom funderar vi över Hockeyettans alla slogans, motsättningar i Kalmar, Peter Nordström i Vimmerby och en […]

Spetspodden är på Vitalis i Göteborg och intervjuar spännande personer!

För en tid sedan hölls det en heldagsseminarium gällande bland annat kundlojalitet.Evenemanget ägde rum på hotell Rival i Stockholm.Som ett konkret och praktiskt led i att bygga nya slags band mellan kund och företag bandade PS-podden samtalet uppe på scenen live.Det kom att handla om företag som bygger lojalitet enligt det gamla sättet och exempel på företag som bygger lojalitet på nya och spännande sätt.Hur gör man som företag för att bibehålla gamla kunder och vinna nya? Vilka vägar går man? Hur har lojalitet mellan kund och företag utvecklats och förändrats de senaste åren? Vilka vägar ska man gå?Från Differ medverkade Peter Nordström och Lisa Hammar.Alla framträdanden och seminarier hölls på engelska så även detta avsnitt är på engelska. See acast.com/privacy for privacy and opt-out information.

Koreapodden berättar om AKA-films produktion av dokumentären om de svenska Koreaveteranerna. Koreaveteranerna tjänstgjorde på det svenska Röda korssjukhuset i Pusan under - och en tid efter - Koreakriget, som pågick från 1950 till 1953. I det här första avsnittet intervjuar militärhistoriker Per Iko filmens initiativtagare, Lars Frisk, samt filmens producent, Peter Nordström.

I detta avsnitt träffar vi Emil Hallström och Peter Nordström från Differ. Vi pratar om en tjänst som ska hjälpa företag att få ut testprodukter på marknaden via e-handlare. Vi startar i en mycket enkel tjänst och slutar i en komplett plattform för att samla in och analysera data

Magnus Nyström See acast.com/privacy for privacy and opt-out information.

I veckans avsnitt av Radiosportens Hockeypodd: Stort strålkastarljus på hockeyallsvenskan och framför allt på de två mest formstarka lagen Karlskrona och AIK. Vi ringer upp Karlskronas fystränare Miro Zalar, som ju även är Radiosportens friidrottsexpert. Zalar håller tabelltrean Malmö som seriens absolut främsta lag. Apropå AIK:s förvandling från krislag till fem raka segrar under nye tränaren Peter Nordström så kommer vi in på fenomenet ÖVERcoachning. Och så undrar vi vilka två lag som SHL vill ha upp från allsvenskan. Medverkande: L-G Jansson och Magnus Wahlman. Redaktör: Martin Sundelius.

Niklas Jihde och Leif Strömberg om hur man hanterar ett landslagsuppehåll som tränare, Jihdes lista och Tomas Kaberles Stanley Cup-fest. Missa heller inte Strömbergs tappra försök att imitera Peter Nordström.